Druggability score-based ranking and ligand type classification of protein-ligand binding sites
AssigneeAinnocence INC
InventorsOrhun Vural, Lurong Pan
Life of this patent
Estimating the term…
Loading patent…
AssigneeAinnocence INC
InventorsOrhun Vural, Lurong Pan
Estimating the term…
The present invention enables the prediction of both the ligand type for protein-ligand binding sites and their druggability scores. The invention provides a computational method to investigate the ligand type and druggability of protein-ligand binding sites. The invention has two distinct training sets for two different prediction methods. The method leverages attention-based deep learning models for both ligand type and druggability prediction tasks. Deep learning models incorporate both channel-based and spatial-based attention mechanisms. The training phase focuses on the coordinates of known ligand binding sites to enhance the accuracy of druggability prediction. The method also provides the capability to update the training set with new data, thereby ensuring continued improvement in the prediction performance. The invention also details a computer device with a memory and processor, storing a computer program to implement the method. The device processes input in the PDB format, performs the necessary cleaning steps, and utilizes the trained models to predict ligand binding site's types and their respective druggability scores. The results are integrated into a table representation and presented to the user, offering an efficient way to understand and apply the predictions.
A method for a druggability score-based ranking and ligand type classification of protein-ligand binding sites (RCLigand), comprising:
A computer device comprising a memory and a processor, wherein the memory stores a computer program and is characterized in that when executing the computer program, the processor implements steps of a method comprising:
Dependencies are inferred from the claim text.